SWK Holdings completes sale of MOD3 contract mfg business to AptarGroup for ~$6.9M

SWK Holdings Corp

Purchase price approximately $6.9M, includes cash previously paid under option, subject to indemnification holdback.
Assets sold are substantially all of MOD3 Pharma's contract manufacturing, formulation, and development services business.
Transaction closed July 15, 2025, after Aptar exercised exclusive option granted under March 2024 Option Agreement.
SWK intends to file the Purchase Agreement as an exhibit to its Q2 2025 Form 10-Q.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.